Show simple item record

dc.contributor.authorLaver, TW
dc.contributor.authorWakeling, MN
dc.contributor.authorKnox, O
dc.contributor.authorColclough, K
dc.contributor.authorWright, CF
dc.contributor.authorEllard, S
dc.contributor.authorHattersley, AT
dc.contributor.authorWeedon, MN
dc.contributor.authorPatel, KA
dc.date.accessioned2022-03-24T09:46:36Z
dc.date.issued2022-02-02
dc.date.updated2022-03-21T17:50:27Z
dc.description.abstractMaturity Onset Diabetes of the Young (MODY) is an autosomal dominant form of monogenic diabetes, reported to be caused by variants in 16 genes. Concern has been raised about whether variants in BLK (MODY11), KLF11 (MODY7) and PAX4 (MODY9) cause MODY. We examined variant-level genetic evidence (co-segregation with diabetes and frequency in population) for published putative pathogenic variants in these genes and used burden testing to test gene-level evidence in a MODY cohort (n=1227) compared to population control (UK Biobank, n=185,898). For comparison we analysed well-established causes of MODY, HNF1A and HNF4A. The published variants in BLK, KLF11 and PAX4 showed poor co-segregation with diabetes (combined LOD scores ≤1.2), compared to HNF1A and HNF4A (LOD scores >9), and are all too common to cause MODY (minor allele frequency >4.95x10-5). Ultra-rare missense and protein-truncating variants (PTVs) were not enriched in a MODY cohort compared to the UK Biobank (PTVs P>0.05, missense P>0.1 for all three genes) while HNF1A and HNF4A were enriched (P<10-6). Sensitivity analyses using different population cohorts supported our results. Variant and gene-level genetic evidence does not support BLK, KLF11 or PAX4 as causes of MODY. They should not be included in MODY diagnostic genetic testing.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.description.sponsorshipResearch Englanden_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.format.mediumPrint-Electronic
dc.identifier.citationPublished online 2 February 2022en_GB
dc.identifier.doihttps://doi.org/10.2337/db21-0844
dc.identifier.grantnumberMR/T00200X/1en_GB
dc.identifier.grantnumber19/0005994en_GB
dc.identifier.grantnumber219606/Z/19/Zen_GB
dc.identifier.grantnumberWT098395/Z/12/Zen_GB
dc.identifier.urihttp://hdl.handle.net/10871/129140
dc.identifierORCID: 0000-0001-6399-0089 (Laver, Thomas W)
dc.identifierScopusID: 6506037245 (Laver, Thomas W)
dc.identifierORCID: 0000-0001-5620-473X (Hattersley, Andrew T)
dc.identifierORCID: 0000-0002-6174-6135 (Weedon, Michael N)
dc.identifierORCID: 0000-0002-9240-8104 (Patel, Kashyap A)
dc.identifierScopusID: 57188657944 (Patel, Kashyap A)
dc.language.isoenen_GB
dc.publisherAmerican Diabetes Associationen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35108381en_GB
dc.relation.urlhttps://gnomad.broadinstitute.org/en_GB
dc.rights© 2022 by the American Diabetes Association. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submissionen_GB
dc.titleEvaluation of Evidence for Pathogenicity Demonstrates that BLK, KLF11 and PAX4 Should not be Included in Diagnostic Testing for MODYen_GB
dc.typeArticleen_GB
dc.date.available2022-03-24T09:46:36Z
dc.identifier.issn0012-1797
exeter.place-of-publicationUnited States
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Diabetes Association via the DOI in this recorden_GB
dc.descriptionData and Resource Availability: UK Biobank data is accessible via application: https://www.ukbiobank.ac.uk/enable-yourresearch. GnomAD data is publically available: https://gnomad.broadinstitute.org/. The MODY cohort data is not publicly available due the limitations of the current ethics and to protect patient confidentiality but is available from the corresponding authors on reasonable request. No applicable resources were generated or analyzed during the current study.en_GB
dc.identifier.eissn1939-327X
dc.identifier.journalDiabetesen_GB
dc.relation.ispartofDiabetes
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-01-30
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2022-02-02
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-03-22T08:52:31Z
refterms.versionFCDAM
refterms.dateFOA2022-03-24T09:46:47Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-02-02


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 by the American Diabetes Association. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission
Except where otherwise noted, this item's licence is described as © 2022 by the American Diabetes Association. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission